A tumor microenvironment-responsive microneedle patch for chemodynamic therapy of oral squamous cell carcinoma
Source abstract
Abstract
Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors of the head and neck, and this disease has become a threat to public health due to its poor prognosis and high fatality rate. Chemodynamic therapy (CDT) is an emerging oncology treatment based on the Fenton reaction. However, the lack of endogenous hydrogen peroxide (H2O2) in tumor cells and the high concentration of glutathione (GSH) that depletes toxic hydroxyl radicals (·OH) significantly impair the efficacy of CDT. Here, we developed a polyvinyl alcohol (PVA)-based soluble microneedle patch (denoted as Fe3O4 + VC-MN) loaded with Fe3O4 nanoparticles (NPs) and vitamin C (VC) for the effective treatment of OSCC. When Fe3O4 + VC-MNs are inserted into the OSCC tissue, the Fe3O4 NPs and VC loaded in the tip of the needle are released in a targeted manner. After VC is converted into oxidized vitamin C (DHA), it can consume GSH in tumor cells and generate sufficient intracellular H2O2in situ. Moreover, by virtue of their peroxidase-like activity, Fe3O4 NPs can induce the generation of lethal ·OH through the Fenton reaction with the aforementioned H2O2, leading to tumor cell ferroptosis and apoptosis, thus achieving CDT. Collectively, this functional microneedle patch provides a more efficient and minimally invasive targeted drug delivery solution for the treatment of OSCC.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Stomatology, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan, 430071, China
Funding
Fundamental Research Funds for the Central Universities · Natural Science Foundation of Hubei Province · Wuhan University
References (40)
Show source-provided references
1. Chamoli · Oral Oncol. · 2021 · 121 · 10545110.1016/j.oraloncology.2021.105451 ↗
2. Sung · CA Cancer J. Clin. · 2021 · 71 · 20910.3322/caac.21660 ↗
3. Chen · ACS Appl. Mater. Interfaces · 2022 · 14 · 5710.1021/acsami.1c14135 ↗
4. Ji · Nanoscale · 2023 · 15 · 894810.1039/D3NR00867C ↗
5. Meng · ACS Nano · 2021 · 15 · 573510.1021/acsnano.1c01248 ↗
6. Gao · Biomaterials · 2016 · 101 · 27210.1016/j.biomaterials.2016.05.051 ↗
7. Cai · Int. J. Nanomed. · 2021 · 16 · 519310.2147/IJN.S321612 ↗
8. Park · Oncol. Rep. · 2018 · 40 · 1787
9. Zhang · Adv. Healthcare Mater. · 2022 · 11 · 210197110.1002/adhm.202101971 ↗
10. Yun · Science · 2015 · 350 · 139110.1126/science.aaa5004 ↗
11. Ren · Free Radical Biol. Med. · 2019 · 134 · 35010.1016/j.freeradbiomed.2019.01.037 ↗
12. Sheng · Adv. Drug Delivery Rev. · 2021 · 179 · 11391910.1016/j.addr.2021.113919 ↗
13. Chen · Nanoscale Horiz. · 2022 · 7 · 71510.1039/D2NH00188H ↗
14. Creighton · Adv. Healthcare Mater. · 2019 · 8 · 180118010.1002/adhm.201801180 ↗
15. Chen · Nat. Nanotechnol. · 2021 · 16 · 93310.1038/s41565-021-00910-7 ↗
16. Khan · J. Controlled Release · 2021 · 338 · 34110.1016/j.jconrel.2021.08.036 ↗
17. Liu · Adv. Sci. · 2022 · 9 · e220259110.1002/advs.202202591 ↗
18. Hao · Bioact. Mater. · 2020 · 5 · 542
19. Lin · J. Am. Chem. Soc. · 2019 · 141 · 993710.1021/jacs.9b03457 ↗
20. Caffarel-Salvador · Sci. Adv. · 2021 · 7 · 262010.1126/sciadv.abe2620 ↗
21. Guo · ACS Nano · 2021 · 15 · 1531610.1021/acsnano.1c06279 ↗
22. Prausnitz · Annu. Rev. Chem. Biomol. Eng. · 2017 · 8 · 17710.1146/annurev-chembioeng-060816-101514 ↗
23. Singh · Recent Pat. Drug Delivery Formulation · 2011 · 5 · 1110.2174/187221111794109484 ↗
24. Ita · Curr. Drug Delivery · 2017 · 14 · 35710.2174/1567201813666160630125636 ↗
25. Yin · ACS Nano · 2021 · 15 · 1784210.1021/acsnano.1c06036 ↗
26. Zhang · ACS Nano · 2022 · 16 · 1016310.1021/acsnano.1c11016 ↗
27. Du · ACS Appl. Mater. Interfaces · 2019 · 11 · 4358810.1021/acsami.9b15668 ↗
28. Jamnongkan · Trans. Nonferrous Met. Soc. China · 2014 · 24 · 338610.1016/S1003-6326(14)63481-6 ↗
29. El-Shafie · Nanomaterials · 2023 · 13 · 144410.3390/nano13091444 ↗
30. Rahmani · J. Mol. Struct. · 2019 · 1196 · 39410.1016/j.molstruc.2019.06.076 ↗
31. Yasaei · Mater. Sci. Eng., C · 2019 · 103 · 10981610.1016/j.msec.2019.109816 ↗
32. Yu · ACS Nano · 2023 · 17 · 1571310.1021/acsnano.3c02964 ↗
33. Wang · Adv. Mater. · 2022 · 34 · e220783210.1002/adma.202207832 ↗
34. Zhang · Front. Pharmacol · 2021 · 12 · 71990510.3389/fphar.2021.719905 ↗
35. Duarte · Mol. Carcinog. · 2019 · 58 · 16110.1002/mc.22911 ↗
36. Cassetta · Nat. Rev. Drug Discovery · 2018 · 17 · 88710.1038/nrd.2018.169 ↗
37. Lin · Nanoscale · 2023 · 7
38. Xu · Adv. Healthcare Mater. · 2020 · 9 · e190150210.1002/adhm.201901502 ↗
39. Xu · Nanoscale · 2019 · 11 · 1753510.1039/C9NR06450H ↗
40. Lan · ACS Appl. Mater. Interfaces · 2018 · 10 · 3306010.1021/acsami.8b12926 ↗